CROSSJECT |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 EUR | -1.96% |
|
-5.94% | -61.77% |
| May. 03 | Crossject: praised for extended agreement on Zepizure | CF |
| May. 02 | Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe | CI |
Official Publications
- Stock Market
- Equities
- ALCJ Stock
- News Crossject
- Official Publications